Trials / Completed
CompletedNCT04769700
Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19
Post-partum Depression, Breastfeeding Adherence, and Fear in Women Giving Birth During the COVID-19 Pandemic.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (actual)
- Sponsor
- Instituto Mexicano del Seguro Social · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to explore whether quarantine measures, social distancing and hospital containment policies among women giving birth during the COVID-19 pandemic enhanced psycho-emotional distress in the immediate postpartum period. The investigators tested for depression using the Edinburgh Postnatal Depression Scale (EPDS) in the first 6 postpartum months, and then used the Fear of COVID-19 Scale, measuring also the adherence and practices of breastfeeding according to WHO.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Edinburgh Postnatal Depression Scale | The Edinburgh Postnatal Depression Scale is a self-administered questionnaire made up of 10 items scored using a four-point Likert scale (0-3) designed to screen for symptoms of postpartum depression. Postpartum depression represents the end of a continuum of severity of symptoms. The present study used a cutoff point for depressive symptomatology risk of higher than 12. |
| BEHAVIORAL | Breast Feeding Adherence | This will be addressed according to the breastfeeding initiation practices according to the WHO. |
| BEHAVIORAL | Fear of Covid-19 Scale | The Fear of Covid-19 Scale is a questionnaire that evaluates fear of the global pandemic caused by the SARS-CoV-2. It consists of seven items, each with a five-point Likert scale of options. The participant is instructed to choose the option that best represents their perception about the statement presented. The maximum possible total is 35 points. The scale's authors indicate that the higher the score is, the higher is the level of the participants' fear of COVID-19. |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2021-02-24
- Last updated
- 2023-10-02
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04769700. Inclusion in this directory is not an endorsement.